Your Best Stock

Stryker Corp SYK

$270.77
−$2.63 (-0.96%)
Market open · Sep 24, 1:10 pm ET
After hours $273.35 -0.02%
Open$273.01
Prev close$273.40
Day range$270.39 – $275.71
Volume778.7K
Market cap$103.86B
P/E (TTM)28.1
Dividend yield1.29%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$6.59B+9.4% YoY
Operating profit$1.66B+42.1% YoY
Net profit$1.28B+44.3% YoY
Diluted EPS$3.30+44.1% YoY
Free cash flow$1.06B+14.1% YoY
Operating cash flow$1.26B

Revenue, last 8 quarters

$5.5BSep '24$6.4BDec '24$5.9BMar '25$6.0BJun '25$6.1BSep '25$7.2BDec '25$6.0BMar '26$6.6BJun '26

Net profit, last 8 quarters

$834.0MSep '24$546.0MDec '24$654.0MMar '25$884.0MJun '25$859.0MSep '25$849.0MDec '25$745.0MMar '26$1.3BJun '26

Diluted EPS by quarter

2.16Sep '241.41Dec '241.69Mar '252.29Jun '252.22Sep '252.20Dec '251.93Mar '263.30Jun '26

Free cash flow by quarter

$1.3BSep '24$1.7BDec '24$127.0MMar '25$928.0MJun '25$1.4BSep '25$1.9BDec '25$415.0MMar '26$1.1BJun '26

Annual revenue

$14.4BFY20$17.1BFY21$18.4BFY22$20.5BFY23$22.6BFY24$25.1BFY25

Profitability & balance sheet

Gross margin65.0%
Operating margin21.7%
Net margin14.4%
Return on equity16.5%
Return on assets7.9%
Return on invested capital10.9%
Current ratio2.16
Liabilities / assets50.0%
Cash & investments$3.48B
Total debt$14.94B
Net cash (debt)-$11.47B
Free cash flow / sales18.2%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • MedSurg and Neurotechnology$3.63B 55.0%
  • Orthopaedics$2.96B 45.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $6.59B $6.02B $25.12B $7.17B $6.06B
Total Operating Revenue $6.59B $6.02B $25.12B $7.17B $6.06B
Cost of Revenue $2.09B $2.21B $9.05B $2.54B $2.21B
Gross Profit $4.50B $3.81B $16.07B $4.63B $3.85B
Operating Expense $2.84B $2.87B $11.01B $2.82B $2.64B
Selling and Admin Expenses $2.23B $2.28B $8.65B $2.23B $2.05B
Research & Development $434.00M $413.00M $1.62B $401.00M $410.00M
Depreciation & Amortization & Depletion $175.00M $180.00M $732.00M $189.00M $189.00M
-Depreciation & Amortization $175.00M $180.00M $732.00M $189.00M $189.00M
Operating Profit $1.66B $936.00M $5.06B $1.81B $1.21B
Net Non-Operating Interest Income (Expense) -$141.00M -$148.00M -$607.00M
Non-Operating Interest Expense $141.00M $148.00M $607.00M
Other Income (Expense) $45.00M $62.00M $62.00M $501.00M -$179.00M
Special Income (Charges) -$1.00M $0.00 -$170.00M -$7.00M -$73.00M
-Less:Impairment of Capital Assets $1.00M $0.00 $170.00M $7.00M $73.00M
Other Non-Operating Income (Expenses) $46.00M $62.00M $232.00M $508.00M -$106.00M
Pretax Profit $1.56B $850.00M $4.51B $1.71B $1.03B
Tax $288.00M $105.00M $1.27B $856.00M $170.00M
Net Profit $1.28B $745.00M $3.25B $849.00M $859.00M
Profit from Continuing Operations $1.28B $745.00M $3.25B $849.00M $859.00M
Net Income to Parent Company $1.28B $745.00M $3.25B $849.00M $859.00M
Net Income to Common Stockholders $1.28B $745.00M $3.25B $849.00M $859.00M
Basic EPS $3.32 $1.95 $8.49 $2.21 $2.25
Diluted EPS $3.30 $1.93 $8.40 $2.20 $2.22
Dividend Per Share $0.88 $0.88 $3.40 $0.88 $0.84

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $47.93B $46.29B $47.84B $47.84B $47.06B
Total Current Assets $14.42B $13.34B $14.76B $14.76B $13.71B
Cash and Cash Equivalents & Short-Term Investments $3.48B $2.97B $4.10B $4.10B $3.34B
-Cash and Cash Equivalents $3.39B $2.88B $4.01B $4.01B $3.26B
-Short Term Investments $85.00M $87.00M $89.00M $89.00M $87.00M
Receivables $3.74B $3.57B $4.04B $4.04B $3.64B
-Accounts Receivable $3.74B $3.57B $4.04B $4.04B $3.64B
Inventory $5.52B $5.42B $5.31B $5.31B $5.37B
Other Current Assets $1.68B $1.38B $1.31B $1.31B $1.36B
Total Non-Current Assets $33.51B $32.95B $33.09B $33.09B $33.35B
Net PPE $3.96B $3.89B $3.88B $3.88B $3.73B
-Gross PPE $7.81B $7.63B $7.54B $7.54B $7.41B
-Accumulated Depreciation -$3.85B -$3.74B -$3.66B -$3.66B -$3.67B
Goodwill and Other Intangible Assets $25.33B $24.70B $24.97B $24.97B $25.10B
-Goodwill $19.58B $19.19B $19.29B $19.29B $19.26B
-Other Intangible Assets $5.74B $5.52B $5.68B $5.68B $5.85B
Non-Current Deferred Assets $994.00M $1.19B $1.10B $1.10B $1.37B
Other Non-Current Assets $3.23B $3.17B $3.14B $3.14B $3.14B
Total Liabilities $23.94B $23.31B $25.42B $25.42B $25.27B
Total Current Liabilities $6.68B $6.32B $7.79B $7.79B $7.41B
Payables $2.23B $2.41B $2.55B $2.55B $1.94B
-Accounts Payable $1.66B $1.59B $1.80B $1.80B $1.50B
-Total Tax Payable $224.00M $476.00M $418.00M $418.00M $118.00M
-Dividends Payable $338.00M $337.00M $337.00M $337.00M $321.00M
Current Accrued Expenses $2.60B $2.53B $2.65B $2.65B $2.42B
Short-Term Debt and Capital Lease Obligation $750.00M $499.00M $1.00B $1.00B $1.75B
-Current Debt $750.00M $499.00M $1.00B $1.00B $1.75B
Total Non-Current Liabilities $17.26B $17.00B $17.63B $17.63B $17.86B
Long Term Accounts Payable and Other Payables $406.00M $403.00M $402.00M $402.00M $400.00M
Long Term Debt and Capital Lease Obligation $14.19B $14.22B $14.86B $14.86B $14.85B
-Long Term Debt $14.19B $14.22B $14.86B $14.86B $14.85B
Other Non-Current Liabilities $2.66B $2.37B $2.37B $2.37B $2.61B
Total Equity $23.99B $22.98B $22.42B $22.42B $21.79B
Stockholders' Equity $23.99B $22.98B $22.42B $22.42B $21.79B
Capital Stock $38.00M $38.00M $38.00M $38.00M $38.00M
-Common Stock $38.00M $38.00M $38.00M $38.00M $38.00M
Additional Paid-In Capital $2.71B $2.65B $2.60B $2.60B $2.55B
Retained Earnings $21.82B $20.88B $20.47B $20.47B $19.96B
Gains/Losses Not Affecting Retained Earnings -$576.00M -$583.00M -$687.00M -$687.00M -$766.00M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $1.26B $581.00M $5.04B $2.14B $1.54B
Net cash flow from continuing operations $1.26B $581.00M $5.04B $2.14B $1.54B
Net Income from Continuing Operations $1.28B $745.00M $3.25B $849.00M $859.00M
Depreciation & Depletion & Amortization $296.00M $300.00M $1.19B $316.00M $309.00M
Deferred Tax $107.00M -$33.00M $392.00M $201.00M $15.00M
Change in Working Capital -$431.00M -$560.00M -$373.00M $709.00M $161.00M
-Change in Receivables -$177.00M $444.00M $127.00M -$397.00M $267.00M
-Change in Inventory -$113.00M -$127.00M -$297.00M $76.00M -$147.00M
-Change in Payables and Accrued Expense $111.00M -$852.00M $267.00M $1.13B $135.00M
-Change In Other Working Capital -$252.00M -$25.00M -$470.00M -$97.00M -$94.00M
Net cash flow from investing -$639.00M -$185.00M -$4.87B -$305.00M -$321.00M
Net Cash Flow from Continuing Investing Activities -$639.00M -$185.00M -$4.87B -$305.00M -$321.00M
Net PPE Purchase and Sale -$202.00M -$166.00M -$761.00M -$268.00M -$187.00M
Net Business Purchase and Sale -$437.00M -$22.00M -$4.80B -$10.00M -$136.00M
Net Investment Purchase and Sale $2.00M $2.00M $750.00M -$8.00M $3.00M
Net Other Investing Changes -$2.00M $1.00M -$60.00M -$19.00M -$1.00M
Financing Cash Flow -$95.00M -$1.51B $113.00M -$1.09B -$339.00M
Net Cash Flow from Continuing Financing Activities -$95.00M -$1.51B $113.00M -$1.09B -$339.00M
Net Issuance Payments Of Debt $250.00M -$1.00B $1.58B -$751.00M -$1.00M
Cash Dividends Paid -$337.00M -$337.00M -$1.28B -$321.00M -$322.00M
Net Other Financing Charges -$8.00M -$173.00M -$182.00M -$21.00M -$16.00M
Ending Cash Balance $3.39B $2.88B $4.01B $4.01B $3.26B
Net Change in Cash $527.00M -$1.11B $291.00M $745.00M $880.00M
Beginning Cash Balance $2.88B $4.01B $3.65B $3.26B $2.38B
Effect of Exchange Rate Changes -$14.00M -$19.00M $68.00M $10.00M $1.00M
Free Cash Flow $1.06B $415.00M $4.28B $1.88B $1.35B
Other Non-Cash Items $42.00M $173.00M $13.00M $61.00M
Scroll to Top